Log in to save to my catalogue

Clinical impact of PSMA-based 18 F-DCFBC PET/CT imaging in patients with biochemically recurrent pro...

Clinical impact of PSMA-based 18 F-DCFBC PET/CT imaging in patients with biochemically recurrent pro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_28894899

Clinical impact of PSMA-based 18 F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

About this item

Full title

Clinical impact of PSMA-based 18 F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

Publisher

Germany

Journal title

European journal of nuclear medicine and molecular imaging, 2018-01, Vol.45 (1), p.4

Language

English

Formats

Publication information

Publisher

Germany

More information

Scope and Contents

Contents

The purpose of our study was to assess
F-DCFBC PET/CT, a PSMA targeted PET agent, for lesion detection and clinical management of biochemical relapse in prostate cancer patients after primary treatment.
This is a prospective IRB-approved study of 68 patients with documented biochemical recurrence after primary local therapy consisting of radi...

Alternative Titles

Full title

Clinical impact of PSMA-based 18 F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_28894899

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_28894899

Other Identifiers

E-ISSN

1619-7089

DOI

10.1007/s00259-017-3818-x

How to access this item